nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—PTGS1—Thalidomide—leprosy	0.186	0.23	CbGbCtD
Eszopiclone—PTGS1—Dapsone—leprosy	0.149	0.184	CbGbCtD
Eszopiclone—CYP2C8—Rifampicin—leprosy	0.104	0.129	CbGbCtD
Eszopiclone—CYP2C8—Dapsone—leprosy	0.0859	0.106	CbGbCtD
Eszopiclone—CYP2C9—Thalidomide—leprosy	0.075	0.0926	CbGbCtD
Eszopiclone—CYP2C9—Rifampicin—leprosy	0.0726	0.0897	CbGbCtD
Eszopiclone—CYP2C9—Dapsone—leprosy	0.0599	0.074	CbGbCtD
Eszopiclone—CYP3A4—Rifampicin—leprosy	0.0422	0.0521	CbGbCtD
Eszopiclone—CYP3A4—Dapsone—leprosy	0.0348	0.043	CbGbCtD
Eszopiclone—Hyporeflexia—Thalidomide—leprosy	0.00318	0.0185	CcSEcCtD
Eszopiclone—Hernia—Thalidomide—leprosy	0.00308	0.018	CcSEcCtD
Eszopiclone—Neck stiffness—Thalidomide—leprosy	0.00304	0.0177	CcSEcCtD
Eszopiclone—TSPO—hindlimb—leprosy	0.00281	0.15	CbGeAlD
Eszopiclone—Nuchal rigidity—Thalidomide—leprosy	0.00279	0.0162	CcSEcCtD
Eszopiclone—Hostility—Thalidomide—leprosy	0.00261	0.0152	CcSEcCtD
Eszopiclone—Vesiculobullous rash—Thalidomide—leprosy	0.00258	0.015	CcSEcCtD
Eszopiclone—Gastric ulcer—Thalidomide—leprosy	0.00249	0.0145	CcSEcCtD
Eszopiclone—TSPO—appendage—leprosy	0.00241	0.129	CbGeAlD
Eszopiclone—Myasthenia—Thalidomide—leprosy	0.0023	0.0134	CcSEcCtD
Eszopiclone—Galactorrhoea—Thalidomide—leprosy	0.00223	0.013	CcSEcCtD
Eszopiclone—Neuralgia—Thalidomide—leprosy	0.00208	0.0121	CcSEcCtD
Eszopiclone—Hepatomegaly—Thalidomide—leprosy	0.00204	0.0119	CcSEcCtD
Eszopiclone—Metrorrhagia—Thalidomide—leprosy	0.00202	0.0118	CcSEcCtD
Eszopiclone—Nystagmus—Thalidomide—leprosy	0.00202	0.0118	CcSEcCtD
Eszopiclone—Hyperlipidaemia—Thalidomide—leprosy	0.00201	0.0117	CcSEcCtD
Eszopiclone—Neuritis—Thalidomide—leprosy	0.00194	0.0113	CcSEcCtD
Eszopiclone—Stupor—Thalidomide—leprosy	0.00194	0.0113	CcSEcCtD
Eszopiclone—Amblyopia—Thalidomide—leprosy	0.00187	0.0109	CcSEcCtD
Eszopiclone—Hyperaesthesia—Thalidomide—leprosy	0.00184	0.0107	CcSEcCtD
Eszopiclone—Rash pustular—Thalidomide—leprosy	0.00181	0.0106	CcSEcCtD
Eszopiclone—Muscular weakness—Dapsone—leprosy	0.00181	0.0105	CcSEcCtD
Eszopiclone—Tingling sensation—Thalidomide—leprosy	0.0018	0.0105	CcSEcCtD
Eszopiclone—Influenza—Dapsone—leprosy	0.00177	0.0103	CcSEcCtD
Eszopiclone—Numbness—Thalidomide—leprosy	0.00174	0.0102	CcSEcCtD
Eszopiclone—Sensory loss—Thalidomide—leprosy	0.00167	0.00972	CcSEcCtD
Eszopiclone—Amenorrhoea—Thalidomide—leprosy	0.00165	0.00959	CcSEcCtD
Eszopiclone—Accidental injury—Thalidomide—leprosy	0.00163	0.00952	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Dapsone—leprosy	0.00162	0.00942	CcSEcCtD
Eszopiclone—Musculoskeletal stiffness—Thalidomide—leprosy	0.00161	0.00939	CcSEcCtD
Eszopiclone—Skin discolouration—Thalidomide—leprosy	0.0016	0.00933	CcSEcCtD
Eszopiclone—Viral infection—Thalidomide—leprosy	0.0016	0.00933	CcSEcCtD
Eszopiclone—Arthropathy—Thalidomide—leprosy	0.00159	0.00926	CcSEcCtD
Eszopiclone—Cellulitis—Thalidomide—leprosy	0.00159	0.00926	CcSEcCtD
Eszopiclone—Thinking abnormal—Thalidomide—leprosy	0.00158	0.0092	CcSEcCtD
Eszopiclone—Oliguria—Thalidomide—leprosy	0.00157	0.00914	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Dapsone—leprosy	0.00155	0.00902	CcSEcCtD
Eszopiclone—Hypercholesterolaemia—Thalidomide—leprosy	0.00153	0.00891	CcSEcCtD
Eszopiclone—Gait disturbance—Thalidomide—leprosy	0.00148	0.00863	CcSEcCtD
Eszopiclone—Coordination abnormal—Thalidomide—leprosy	0.00147	0.00858	CcSEcCtD
Eszopiclone—Hepatocellular injury—Thalidomide—leprosy	0.00145	0.00842	CcSEcCtD
Eszopiclone—Pharyngitis—Dapsone—leprosy	0.00141	0.0082	CcSEcCtD
Eszopiclone—Depressed level of consciousness—Thalidomide—leprosy	0.0014	0.00813	CcSEcCtD
Eszopiclone—Colitis—Thalidomide—leprosy	0.00139	0.00809	CcSEcCtD
Eszopiclone—Neuropathy—Thalidomide—leprosy	0.00136	0.00791	CcSEcCtD
Eszopiclone—TSPO—blood vessel—leprosy	0.00134	0.0718	CbGeAlD
Eszopiclone—Dry eye—Thalidomide—leprosy	0.00134	0.00778	CcSEcCtD
Eszopiclone—Cramps of lower extremities—Thalidomide—leprosy	0.00133	0.00774	CcSEcCtD
Eszopiclone—Tinnitus—Dapsone—leprosy	0.00132	0.0077	CcSEcCtD
Eszopiclone—Rash maculo-papular—Thalidomide—leprosy	0.00131	0.00766	CcSEcCtD
Eszopiclone—Lightheadedness—Thalidomide—leprosy	0.00129	0.00754	CcSEcCtD
Eszopiclone—Gynaecomastia—Thalidomide—leprosy	0.00129	0.00754	CcSEcCtD
Eszopiclone—Hypertonia—Thalidomide—leprosy	0.00127	0.00738	CcSEcCtD
Eszopiclone—Mental disability—Thalidomide—leprosy	0.00126	0.00731	CcSEcCtD
Eszopiclone—Euphoric mood—Thalidomide—leprosy	0.00124	0.00724	CcSEcCtD
Eszopiclone—Lymphadenopathy—Thalidomide—leprosy	0.00123	0.00717	CcSEcCtD
Eszopiclone—Thrombophlebitis—Thalidomide—leprosy	0.00121	0.00706	CcSEcCtD
Eszopiclone—Photosensitivity—Thalidomide—leprosy	0.0012	0.00696	CcSEcCtD
Eszopiclone—Eczema—Thalidomide—leprosy	0.00117	0.0068	CcSEcCtD
Eszopiclone—Vision blurred—Dapsone—leprosy	0.00116	0.00678	CcSEcCtD
Eszopiclone—Injury—Thalidomide—leprosy	0.00114	0.00665	CcSEcCtD
Eszopiclone—Libido decreased—Thalidomide—leprosy	0.00113	0.00659	CcSEcCtD
Eszopiclone—Amnesia—Thalidomide—leprosy	0.00112	0.00651	CcSEcCtD
Eszopiclone—Increased appetite—Thalidomide—leprosy	0.00112	0.00651	CcSEcCtD
Eszopiclone—Vertigo—Dapsone—leprosy	0.00111	0.00646	CcSEcCtD
Eszopiclone—Dermatitis bullous—Thalidomide—leprosy	0.0011	0.0064	CcSEcCtD
Eszopiclone—Arthritis—Thalidomide—leprosy	0.00108	0.00629	CcSEcCtD
Eszopiclone—Diplopia—Thalidomide—leprosy	0.00105	0.00611	CcSEcCtD
Eszopiclone—Osteoarthritis—Thalidomide—leprosy	0.00105	0.00611	CcSEcCtD
Eszopiclone—Disturbance in sexual arousal—Thalidomide—leprosy	0.00104	0.00607	CcSEcCtD
Eszopiclone—Affect lability—Thalidomide—leprosy	0.00103	0.00602	CcSEcCtD
Eszopiclone—Migraine—Thalidomide—leprosy	0.00103	0.00602	CcSEcCtD
Eszopiclone—Face oedema—Thalidomide—leprosy	0.00101	0.0059	CcSEcCtD
Eszopiclone—Mood swings—Thalidomide—leprosy	0.000995	0.00579	CcSEcCtD
Eszopiclone—Ataxia—Thalidomide—leprosy	0.000987	0.00575	CcSEcCtD
Eszopiclone—Tachycardia—Dapsone—leprosy	0.000984	0.00573	CcSEcCtD
Eszopiclone—Dehydration—Thalidomide—leprosy	0.000976	0.00569	CcSEcCtD
Eszopiclone—Dry skin—Thalidomide—leprosy	0.000962	0.0056	CcSEcCtD
Eszopiclone—Hypokalaemia—Thalidomide—leprosy	0.000956	0.00557	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000945	0.00551	CcSEcCtD
Eszopiclone—Cramp muscle—Thalidomide—leprosy	0.000945	0.00551	CcSEcCtD
Eszopiclone—Muscular weakness—Thalidomide—leprosy	0.000926	0.00539	CcSEcCtD
Eszopiclone—Insomnia—Dapsone—leprosy	0.000912	0.00531	CcSEcCtD
Eszopiclone—Dysphagia—Thalidomide—leprosy	0.000907	0.00529	CcSEcCtD
Eszopiclone—Influenza—Thalidomide—leprosy	0.000907	0.00529	CcSEcCtD
Eszopiclone—Bronchitis—Thalidomide—leprosy	0.000873	0.00508	CcSEcCtD
Eszopiclone—Pollakiuria—Thalidomide—leprosy	0.000838	0.00488	CcSEcCtD
Eszopiclone—Erectile dysfunction—Thalidomide—leprosy	0.000836	0.00487	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Thalidomide—leprosy	0.000828	0.00482	CcSEcCtD
Eszopiclone—Weight increased—Thalidomide—leprosy	0.000826	0.00481	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Dapsone—leprosy	0.000824	0.0048	CcSEcCtD
Eszopiclone—Weight decreased—Thalidomide—leprosy	0.000821	0.00478	CcSEcCtD
Eszopiclone—Drowsiness—Thalidomide—leprosy	0.000809	0.00471	CcSEcCtD
Eszopiclone—Depression—Thalidomide—leprosy	0.000807	0.0047	CcSEcCtD
Eszopiclone—Body temperature increased—Dapsone—leprosy	0.000797	0.00464	CcSEcCtD
Eszopiclone—Abdominal pain—Dapsone—leprosy	0.000797	0.00464	CcSEcCtD
Eszopiclone—GABRG3—testis—leprosy	0.000793	0.0425	CbGeAlD
Eszopiclone—Neuropathy peripheral—Thalidomide—leprosy	0.000793	0.00462	CcSEcCtD
Eszopiclone—Stomatitis—Thalidomide—leprosy	0.000789	0.00459	CcSEcCtD
Eszopiclone—Conjunctivitis—Thalidomide—leprosy	0.000786	0.00458	CcSEcCtD
Eszopiclone—GABRG3—nervous system—leprosy	0.000778	0.0417	CbGeAlD
Eszopiclone—Sweating—Thalidomide—leprosy	0.000776	0.00452	CcSEcCtD
Eszopiclone—Haematuria—Thalidomide—leprosy	0.000771	0.00449	CcSEcCtD
Eszopiclone—Epistaxis—Thalidomide—leprosy	0.000763	0.00444	CcSEcCtD
Eszopiclone—PTGS1—blood vessel—leprosy	0.000746	0.04	CbGeAlD
Eszopiclone—Rhinitis—Thalidomide—leprosy	0.000728	0.00424	CcSEcCtD
Eszopiclone—Hepatitis—Thalidomide—leprosy	0.000726	0.00423	CcSEcCtD
Eszopiclone—Hypoaesthesia—Thalidomide—leprosy	0.000723	0.00421	CcSEcCtD
Eszopiclone—Pharyngitis—Thalidomide—leprosy	0.000721	0.0042	CcSEcCtD
Eszopiclone—Oedema peripheral—Thalidomide—leprosy	0.000716	0.00417	CcSEcCtD
Eszopiclone—TSPO—eye—leprosy	0.000714	0.0382	CbGeAlD
Eszopiclone—Erythema multiforme—Thalidomide—leprosy	0.000687	0.004	CcSEcCtD
Eszopiclone—Tinnitus—Thalidomide—leprosy	0.000677	0.00394	CcSEcCtD
Eszopiclone—GABRA4—tendon—leprosy	0.000668	0.0358	CbGeAlD
Eszopiclone—Chills—Thalidomide—leprosy	0.000652	0.0038	CcSEcCtD
Eszopiclone—Alopecia—Thalidomide—leprosy	0.000642	0.00374	CcSEcCtD
Eszopiclone—Vomiting—Dapsone—leprosy	0.000641	0.00373	CcSEcCtD
Eszopiclone—Headache—Dapsone—leprosy	0.000631	0.00368	CcSEcCtD
Eszopiclone—TSPO—skin of body—leprosy	0.000621	0.0333	CbGeAlD
Eszopiclone—Tension—Thalidomide—leprosy	0.00062	0.00361	CcSEcCtD
Eszopiclone—Dysgeusia—Thalidomide—leprosy	0.000619	0.00361	CcSEcCtD
Eszopiclone—Nervousness—Thalidomide—leprosy	0.000614	0.00358	CcSEcCtD
Eszopiclone—Back pain—Thalidomide—leprosy	0.000612	0.00356	CcSEcCtD
Eszopiclone—GABRA5—testis—leprosy	0.00061	0.0327	CbGeAlD
Eszopiclone—Muscle spasms—Thalidomide—leprosy	0.000608	0.00354	CcSEcCtD
Eszopiclone—Nausea—Dapsone—leprosy	0.000599	0.00349	CcSEcCtD
Eszopiclone—GABRA5—nervous system—leprosy	0.000598	0.032	CbGeAlD
Eszopiclone—Vision blurred—Thalidomide—leprosy	0.000596	0.00347	CcSEcCtD
Eszopiclone—Tremor—Thalidomide—leprosy	0.000592	0.00345	CcSEcCtD
Eszopiclone—Ill-defined disorder—Thalidomide—leprosy	0.000587	0.00342	CcSEcCtD
Eszopiclone—Anaemia—Thalidomide—leprosy	0.000584	0.0034	CcSEcCtD
Eszopiclone—Agitation—Thalidomide—leprosy	0.000581	0.00338	CcSEcCtD
Eszopiclone—Angioedema—Thalidomide—leprosy	0.000578	0.00336	CcSEcCtD
Eszopiclone—Malaise—Thalidomide—leprosy	0.00057	0.00332	CcSEcCtD
Eszopiclone—Vertigo—Thalidomide—leprosy	0.000568	0.00331	CcSEcCtD
Eszopiclone—GABRA3—testis—leprosy	0.000568	0.0304	CbGeAlD
Eszopiclone—Palpitations—Thalidomide—leprosy	0.000559	0.00325	CcSEcCtD
Eszopiclone—GABRA3—nervous system—leprosy	0.000557	0.0298	CbGeAlD
Eszopiclone—Convulsion—Thalidomide—leprosy	0.000548	0.00319	CcSEcCtD
Eszopiclone—Hypertension—Thalidomide—leprosy	0.000546	0.00318	CcSEcCtD
Eszopiclone—GABRA4—nervous system—leprosy	0.000543	0.0291	CbGeAlD
Eszopiclone—Myalgia—Thalidomide—leprosy	0.000538	0.00314	CcSEcCtD
Eszopiclone—Chest pain—Thalidomide—leprosy	0.000538	0.00314	CcSEcCtD
Eszopiclone—Anxiety—Thalidomide—leprosy	0.000536	0.00312	CcSEcCtD
Eszopiclone—Discomfort—Thalidomide—leprosy	0.000532	0.0031	CcSEcCtD
Eszopiclone—Dry mouth—Thalidomide—leprosy	0.000526	0.00307	CcSEcCtD
Eszopiclone—Confusional state—Thalidomide—leprosy	0.00052	0.00303	CcSEcCtD
Eszopiclone—Infection—Thalidomide—leprosy	0.000513	0.00299	CcSEcCtD
Eszopiclone—Tachycardia—Thalidomide—leprosy	0.000504	0.00293	CcSEcCtD
Eszopiclone—Hyperhidrosis—Thalidomide—leprosy	0.000499	0.00291	CcSEcCtD
Eszopiclone—Anorexia—Thalidomide—leprosy	0.000492	0.00286	CcSEcCtD
Eszopiclone—TSPO—tendon—leprosy	0.000473	0.0253	CbGeAlD
Eszopiclone—Musculoskeletal discomfort—Thalidomide—leprosy	0.00047	0.00274	CcSEcCtD
Eszopiclone—Insomnia—Thalidomide—leprosy	0.000467	0.00272	CcSEcCtD
Eszopiclone—Paraesthesia—Thalidomide—leprosy	0.000463	0.0027	CcSEcCtD
Eszopiclone—GABRB2—testis—leprosy	0.000463	0.0248	CbGeAlD
Eszopiclone—Dyspnoea—Thalidomide—leprosy	0.00046	0.00268	CcSEcCtD
Eszopiclone—Somnolence—Thalidomide—leprosy	0.000459	0.00267	CcSEcCtD
Eszopiclone—Dyspepsia—Thalidomide—leprosy	0.000454	0.00265	CcSEcCtD
Eszopiclone—GABRG2—nervous system—leprosy	0.000454	0.0243	CbGeAlD
Eszopiclone—GABRB2—nervous system—leprosy	0.000454	0.0243	CbGeAlD
Eszopiclone—Decreased appetite—Thalidomide—leprosy	0.000449	0.00261	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Thalidomide—leprosy	0.000446	0.00259	CcSEcCtD
Eszopiclone—Fatigue—Thalidomide—leprosy	0.000445	0.00259	CcSEcCtD
Eszopiclone—Pain—Thalidomide—leprosy	0.000441	0.00257	CcSEcCtD
Eszopiclone—Constipation—Thalidomide—leprosy	0.000441	0.00257	CcSEcCtD
Eszopiclone—Feeling abnormal—Thalidomide—leprosy	0.000425	0.00248	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Thalidomide—leprosy	0.000422	0.00246	CcSEcCtD
Eszopiclone—GABRA2—nervous system—leprosy	0.000415	0.0222	CbGeAlD
Eszopiclone—Urticaria—Thalidomide—leprosy	0.00041	0.00239	CcSEcCtD
Eszopiclone—Abdominal pain—Thalidomide—leprosy	0.000408	0.00238	CcSEcCtD
Eszopiclone—Body temperature increased—Thalidomide—leprosy	0.000408	0.00238	CcSEcCtD
Eszopiclone—GABRA1—nervous system—leprosy	0.000401	0.0215	CbGeAlD
Eszopiclone—TSPO—testis—leprosy	0.000391	0.021	CbGeAlD
Eszopiclone—TSPO—nervous system—leprosy	0.000384	0.0206	CbGeAlD
Eszopiclone—Hypersensitivity—Thalidomide—leprosy	0.00038	0.00221	CcSEcCtD
Eszopiclone—Asthenia—Thalidomide—leprosy	0.00037	0.00216	CcSEcCtD
Eszopiclone—Pruritus—Thalidomide—leprosy	0.000365	0.00213	CcSEcCtD
Eszopiclone—Diarrhoea—Thalidomide—leprosy	0.000353	0.00206	CcSEcCtD
Eszopiclone—PTGS1—skin of body—leprosy	0.000346	0.0185	CbGeAlD
Eszopiclone—Dizziness—Thalidomide—leprosy	0.000341	0.00199	CcSEcCtD
Eszopiclone—Vomiting—Thalidomide—leprosy	0.000328	0.00191	CcSEcCtD
Eszopiclone—Rash—Thalidomide—leprosy	0.000325	0.00189	CcSEcCtD
Eszopiclone—Dermatitis—Thalidomide—leprosy	0.000325	0.00189	CcSEcCtD
Eszopiclone—Headache—Thalidomide—leprosy	0.000323	0.00188	CcSEcCtD
Eszopiclone—Nausea—Thalidomide—leprosy	0.000307	0.00179	CcSEcCtD
Eszopiclone—CYP2C8—testis—leprosy	0.000269	0.0144	CbGeAlD
Eszopiclone—PTGS1—tendon—leprosy	0.000263	0.0141	CbGeAlD
Eszopiclone—PTGS1—testis—leprosy	0.000218	0.0117	CbGeAlD
Eszopiclone—PTGS1—nervous system—leprosy	0.000214	0.0114	CbGeAlD
Eszopiclone—CYP3A4—nervous system—leprosy	0.000179	0.00956	CbGeAlD
